Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 20, 2018
Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain
Malgorzata Maciukiewicz, Ilona Gorbovskaya, Arun K Tiwari, et al.
Journal of Affective Disorders
|
May 27, 2014
FKBP5 polymorphism is associated with major depression but not with bipolar disorder
Aleksandra Szczepankiewicz, Anna Leszczyńska-Rodziewicz, Joanna Pawlak, et al.
Biomedicines
|
December 23, 2023
BRD3 Regulates the Inflammatory and Stress Response in Rheumatoid Arthritis Synovial Fibroblasts
Tanja Seifritz, Matthias Brunner, Eva Camarillo Retamosa, et al.
Schizophrenia Research
|
April 24, 2012
Analysis of OPCRIT results indicate the presence of a novel 'social functioning' domain and complex structure of other dimensions in the Wielkopolska (Poland) population
Malgorzata Maciukiewicz, Piotr M Czerski, Anna Leszczynska-Rodziewicz, et al.
Journal of Psychiatric Research
|
February 7, 2018
GWAS-based machine learning approach to predict duloxetine response in major depressive disorder
Malgorzata Maciukiewicz, Victoria S Marshe, Anne-Christin Hauschild, et al.
Pharmacogenomics
|
November 12, 2015
Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder
Malgorzata Maciukiewicz, Victoria S Marshe, Arun K Tiwari, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 4, 2020
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia
Farhana Islam, Malgorzata Maciukiewicz, Natalie Freeman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2020
Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions
Victoria S Marshe, Farhana Islam, Malgorzata Maciukiewicz, et al.
Pharmacogenomics
|
December 16, 2015
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response
Eric Huang, Malgorzata Maciukiewicz, Clement C Zai, et al.
Schizophrenia Research
|
August 27, 2019
Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans
Malgorzata Maciukiewicz, Arun K Tiwari, Clement C Zai, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Neural Transmission (Vienna, Austria : 1996)
|
September 20, 2018
Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain
Malgorzata Maciukiewicz, Ilona Gorbovskaya, Arun K Tiwari, et al.
Journal of Affective Disorders
|
May 27, 2014
FKBP5 polymorphism is associated with major depression but not with bipolar disorder
Aleksandra Szczepankiewicz, Anna Leszczyńska-Rodziewicz, Joanna Pawlak, et al.
Biomedicines
|
December 23, 2023
BRD3 Regulates the Inflammatory and Stress Response in Rheumatoid Arthritis Synovial Fibroblasts
Tanja Seifritz, Matthias Brunner, Eva Camarillo Retamosa, et al.
Schizophrenia Research
|
April 24, 2012
Analysis of OPCRIT results indicate the presence of a novel 'social functioning' domain and complex structure of other dimensions in the Wielkopolska (Poland) population
Malgorzata Maciukiewicz, Piotr M Czerski, Anna Leszczynska-Rodziewicz, et al.
Journal of Psychiatric Research
|
February 7, 2018
GWAS-based machine learning approach to predict duloxetine response in major depressive disorder
Malgorzata Maciukiewicz, Victoria S Marshe, Anne-Christin Hauschild, et al.
Pharmacogenomics
|
November 12, 2015
Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder
Malgorzata Maciukiewicz, Victoria S Marshe, Arun K Tiwari, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 4, 2020
Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia
Farhana Islam, Malgorzata Maciukiewicz, Natalie Freeman, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2020
Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions
Victoria S Marshe, Farhana Islam, Malgorzata Maciukiewicz, et al.
Pharmacogenomics
|
December 16, 2015
Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response
Eric Huang, Malgorzata Maciukiewicz, Clement C Zai, et al.
Schizophrenia Research
|
August 27, 2019
Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans
Malgorzata Maciukiewicz, Arun K Tiwari, Clement C Zai, et al.
Page
of 4